For patients who cannot tolerate large volumes of fluids, such as those with cardiac or renal dysfunction, alternative pharmacological interventions may be necessary. Acetazolamide, a carbonic anhydrase inhibitor given as 250 to 500 mg intravenously or orally once or twice daily, promotes bicarbonate excretion by the kidneys and corrects the alkalosis without adding fluid; the bicarbonaturia it produces also wastes potassium, so serum potassium must be replaced and followed, and the effect is lost when the GFR is very low. This is particularly useful in patients with congestive heart failure or impaired kidney function. Potassium-sparing diuretics, such as spironolactone or amiloride, may also be beneficial in reducing fluid overload while correcting hypokalemia.
H2-Receptor Antagonists and Proton Pump Inhibitors
H2-receptor antagonists play an important role in preventing and managing metabolic alkalosis caused by gastric acid losses. These drugs reduce gastric acid secretion, which is particularly useful in postoperative patients or those with nasogastric suction. H2-receptor antagonists such as famotidine (ranitidine was withdrawn from the United States market in 2020 because of nitrosamine contamination), and more potently proton pump inhibitors such as pantoprazole, reduce the volume and acidity of gastric secretions, thereby preventing further chloride and hydrogen ion loss through a nasogastric tube. These agents are also beneficial in patients with conditions like Zollinger-Ellison syndrome, where gastric hypersecretion leads to persistent metabolic alkalosis.
Severe and Refractory Alkalosis
In cases where metabolic alkalosis is severe or resistant to standard treatments, more aggressive interventions are required. Direct infusion of hydrochloric acid (HCl) is one of the fastest ways to correct severe alkalosis (pH > 7.55). HCl (0.1 to 0.2 N) is administered through a central venous catheter at no more than about 0.2 mEq/kg/h; the hydrogen ion deficit is estimated as 0.5 x body weight (kg) x (measured bicarbonate - 24), and only part of it is given before the blood gas is rechecked. This method requires close monitoring, as HCl infusion can cause hemolysis and tissue necrosis if it extravasates, and it is rarely needed. In patients with kidney failure, hemodialysis or continuous renal replacement therapy with a low-bicarbonate dialysate corrects the alkalosis instead. An alternative option is ammonium chloride, which can be used in patients with normal liver and kidney function. It is metabolized by the liver into urea and hydrogen ions, indirectly correcting alkalosis. However, it is contraindicated in patients with liver or kidney disease due to the risk of ammonia toxicity.
| Therapy | Role | Cautions |
|---|---|---|
| Isotonic sodium chloride (0.9% NaCl) | Primary treatment for chloride-responsive alkalosis; restores chloride and extracellular fluid volume so the kidneys can excrete excess bicarbonate; 3–5 L may be needed | Monitor cardiovascular status during infusion, particularly with cardiac conditions |
| Potassium chloride | Preferred correction for the hypokalemia that commonly accompanies alkalosis; oral in mild cases | Intravenous route for severe hypokalemia with arrhythmias or neuromuscular dysfunction; monitor serum potassium to avoid overcorrection to hyperkalemia |
| Acetazolamide (250-500 mg IV or PO, once or twice daily) | Carbonic anhydrase inhibitor that promotes renal bicarbonate excretion without adding fluid | Chosen when large fluid volumes are not tolerated, as in congestive heart failure; wastes potassium, so replace and follow it; ineffective at a very low GFR |
| Potassium-sparing diuretics (spironolactone, amiloride) | Reduce fluid overload while correcting hypokalemia | — |
| H2-receptor antagonists (famotidine) and proton pump inhibitors | Reduce the volume and acidity of gastric secretions, preventing further chloride loss | Particularly useful with nasogastric suction, in postoperative patients, and in Zollinger-Ellison syndrome |
| Hydrochloric acid infusion | Fastest correction of severe alkalosis (pH above 7.55); hydrogen ion deficit = 0.5 x kg x (HCO3 - 24), given as 0.1-0.2 N at up to 0.2 mEq/kg/h | Given through a central venous catheter with close monitoring; can cause hemolysis and tissue necrosis; rarely needed |
| Ammonium chloride | Metabolized by the liver to urea and hydrogen ions, indirectly correcting the alkalosis | Requires normal liver and kidney function; contraindicated in liver or kidney disease because of ammonia toxicity |
| Hemodialysis or CRRT with a low-bicarbonate dialysate | Corrects refractory alkalosis in patients with kidney failure | Requires dialysis access |
